The global orthopedic prosthetic devices market is valued at US$ 8.20 Billion in 2026 and is projected to reach US$ 20.39 Billion by 2033, growing at a CAGR of 13.9%.
Growth is driven by rising diabetes and vascular disease-related amputations, increasing rehabilitation demand, and expanding reimbursement coverage for advanced prosthetic devices.
Lower extremity prosthetics lead the market with 55.0% share due to the high prevalence of lower-limb amputations and recurring replacement demand.
North America holds the largest share at 39.0%, supported by strong reimbursement systems, advanced healthcare infrastructure, and veteran rehabilitation programs.
Key opportunities include digitally fabricated prosthetics, remote fitting technologies, and expanding access to prosthetic care in emerging economies.